Ftse Mib
34.535,59
-0,83%
DAX
18.673,38
-0,50%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,00%
Bitcoin
71.186,76
-0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ InVivo Therapeutics Holdings Corporation (NVIV) InVivo Therapeutics Holdings Corporation (NVIV) Notizie

NVIV

InVivo Therapeutics (NVIV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVIV
DataOraFonteTitoloSimboloCompagnia
21/03/202419:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202420:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202420:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202419:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/02/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202314:35Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202314:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/11/202322:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/202322:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
25/04/202323:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202314:55Business WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/03/202322:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202223:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202212:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/11/202223:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202222:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202222:01Business WireInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202217:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/10/202214:00Business WireInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/09/202214:00Business WireInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/09/202212:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
18/08/202215:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/08/202222:03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
13/07/202214:30Business WireInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General CounselNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/07/202222:32Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/06/202214:30Business WireInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/06/202214:30Business WireInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury StudyNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/04/202222:30Business WireInVivo Therapeutics Announces Reverse Stock SplitNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVIV

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
G
Generali
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
STMMI
ST Microelectronics
BIT
LDO
Leonardo
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network